Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Lung Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Published in Lung Cancer

Journal Scan / Research · February 03, 2022

Immune Biomarkers and Response to ICIs in BRAF-Altered Lung Cancer

British Journal of Cancer


Additional Info

British Journal of Cancer
Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers
Br. J. Cancer 2021 Dec 28;[EPub Ahead of Print], YR Murciano-Goroff, T Pak, S Mondaca, JR Flynn, J Montecalvo, N Rekhtman, D Halpenny, AJ Plodkowski, SL Wu, MG Kris, PK Paik, GJ Riely, HA Yu, CM Rudin, MD Hellmann, JD Land, LW Buie, G Heller, P Lito, R Yaeger, A Drilon, D Liu, BT Li, M Offin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading